Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis.
about
Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis.Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System.
P2860
Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hepatitis B virus screening be ...... a cost-effectiveness analysis.
@en
type
label
Hepatitis B virus screening be ...... a cost-effectiveness analysis.
@en
prefLabel
Hepatitis B virus screening be ...... a cost-effectiveness analysis.
@en
P2093
P2860
P1476
Hepatitis B virus screening be ...... a cost-effectiveness analysis.
@en
P2093
Hong-Anh Tu
Jordan J Feld
Kathleen I Pritchard
Kelvin K Chan
Lisa K Hicks
P2860
P2888
P304
P356
10.1007/S10549-015-3382-7
P407
P577
2015-05-12T00:00:00Z
P6179
1038865606